中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
171-172
,共2页
左卡尼汀%参麦注射液%缺血性心肌病%心力衰竭
左卡尼汀%參麥註射液%缺血性心肌病%心力衰竭
좌잡니정%삼맥주사액%결혈성심기병%심력쇠갈
Levoearnitine%Shenmai injection%Ischemic cardiomyopathy%Heart failure
目的：研究左卡尼汀联合参麦注射液治疗缺血性心肌病心力衰竭的临床疗效。方法按照数字表法将2013年1月～2015年1月我院收治的缺血性心肌病心力衰竭患者126例随机分成对照组和试验组各63例，对照组采用常规疗法，试验组在对照组治疗基础上使用左卡尼汀联合参麦注射液治疗，对两组的治疗有效率以及左室射血分数（LVEF）、左室短径缩短率（LVFS）、每搏量（SV）及心排出量（CO）等心脏超声指标进行比较。结果试验组的治疗有效率高于对照组患者，比较差异具有统计学意义，P<0.05；试验组LVEF、FS、SV、CO优于对照组，比较差异具有统计学意义，P<0.05。结论左卡尼汀联合参麦注射液治疗缺血性心肌病心力衰竭对心功能的改善具有显著的作用、临床疗效确切。
目的：研究左卡尼汀聯閤參麥註射液治療缺血性心肌病心力衰竭的臨床療效。方法按照數字錶法將2013年1月～2015年1月我院收治的缺血性心肌病心力衰竭患者126例隨機分成對照組和試驗組各63例，對照組採用常規療法，試驗組在對照組治療基礎上使用左卡尼汀聯閤參麥註射液治療，對兩組的治療有效率以及左室射血分數（LVEF）、左室短徑縮短率（LVFS）、每搏量（SV）及心排齣量（CO）等心髒超聲指標進行比較。結果試驗組的治療有效率高于對照組患者，比較差異具有統計學意義，P<0.05；試驗組LVEF、FS、SV、CO優于對照組，比較差異具有統計學意義，P<0.05。結論左卡尼汀聯閤參麥註射液治療缺血性心肌病心力衰竭對心功能的改善具有顯著的作用、臨床療效確切。
목적：연구좌잡니정연합삼맥주사액치료결혈성심기병심력쇠갈적림상료효。방법안조수자표법장2013년1월～2015년1월아원수치적결혈성심기병심력쇠갈환자126례수궤분성대조조화시험조각63례，대조조채용상규요법，시험조재대조조치료기출상사용좌잡니정연합삼맥주사액치료，대량조적치료유효솔이급좌실사혈분수（LVEF）、좌실단경축단솔（LVFS）、매박량（SV）급심배출량（CO）등심장초성지표진행비교。결과시험조적치료유효솔고우대조조환자，비교차이구유통계학의의，P<0.05；시험조LVEF、FS、SV、CO우우대조조，비교차이구유통계학의의，P<0.05。결론좌잡니정연합삼맥주사액치료결혈성심기병심력쇠갈대심공능적개선구유현저적작용、림상료효학절。
Objective To research the clinical effects of shenmai injection combined with levoearnitine in treatment of ischemic cardiomyopathy heart failure(ICHF). Methods 126 cases patients with ICHF in our hospital from January 2013 to January 2015 was divided into control group and experimental group,each group had 63 case. Applied rountine method for control group ,besides it,applied shenmai injection combined with levoearnitine for experimental group. Compared The effective rate of treatment and left ventric eject fraction(LVEF),fractional shortening(FS)of left ventricular,stroke volume (SV)and cardiac output(CO). Results The effective rate of treatment of experimental group was higher than that of control group,the difference was significant(P<0.05).The index of Echocar-diography LVEF、FS、SV、CO were better than that of control group,the difference was significant (P<0.05). Conclusion The use of shenmai injection combined with levoearnitine in treatment of ischemic cardiomyopathy heart failure has a significant role for improve heart function. It has Clinical curative effect.
